Verition Fund Management
ONEM

Verition Fund Management’s 1Life Healthcare ONEM Stock Holding History

Verition Fund Management’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,769,693
Closed -$29.6M – 2753
2022
Q4 		$29.6M Buy
1,769,693
+690,859
+64% +$11.7M 0.46% 32
2022
Q3 		$18.5M Buy
+1,078,834
New +$16.9M 0.21% 98
2021
Q3 		– Sell
-15,919
Closed -$526K – 2440
2021
Q2 		$526K Buy
15,919
+10,443
+191% +$394K ﹤0.01% 1066
2021
Q1 		$214K Buy
+5,476
New +$257K ﹤0.01% 1304

Verition Fund Management's ONEM Position: Q1 2023 in Review

Verition Fund Management sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 1,769,693 shares — an estimated $29.6M sold.

Verition Fund Management first reported a position in ONEM in Q1 2021 and held it in 4 quarters. The position peaked at $29.6M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Verition Fund Management reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Verition Fund Management sold 1,769,693 1Life Healthcare shares in Q1 2023, an estimated $29.6M.
  • Verition Fund Management first reported a position in 1Life Healthcare in Q1 2021 and held it in 4 quarters.
  • Verition Fund Management's 1Life Healthcare position peaked at $29.6M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.